We believe that basic research and the cultivation of scientific knowledge is critical for us to stay connected with our customers and to drive scientific breakthroughs. At NEB, over 30 labs participate in research projects, which are aided by post-doctoral fellows and students in Masters and Ph.D. programs. NEB researchers have authored or co-authored over 1,200 publications (as of 1/19) many of which are in peer-reviewed journals. Further, NEB products have been used successfully in numerous publications by scientists throughout the world.
Use the filters below to search for publications by year, journal or keyword. This list may be sorted by clicking on any column header.
Search Our Publications
In addition to using the filters to search, this list may be sorted by clicking on the sort options. Titles in orange are linked to the full article text.
Use any combination of the facets and/or perform a keyword(s) search to narrow your results below.
Your search returned 2120 results.
|2018||Targeting GLP-1 receptor trafficking to improve agonist efficacy||Nat. Commun. 9(1): 1602. doi: 10.1038/s41467-018-03941-2||Jones, B., Buenaventura, T., Kanda, N., Chabosseau, P., Owen, B.M., Scott, R., Goldin, R., Angkathunyakul, N., Corrêa, I.R., Jr., Bosco, D., Johnson, P.R., Piemonti, L., Marchetti, P., Shapiro, A.M.J., Cochran, B.J., Hanyaloglu, A.C., Inoue, A., Tan, T., Rutter, G.A., Tomas, A., Bloom, S.R.|
|2011||Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system||BMC Neurosci||Gonzalez, A.M. et al.||Phage Display|
|2010||Targeting of embryonic stem cells by peptide-conjugated quantum dots||PLoS One||Lu, S. et al.|
|Targeting of tumor blood vessels|
|2009||Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo||Mol. Cancer Res.||Mueller, J. et al.|
|2011||Targeting the Wolbachia cell division Protein FtsZ as a wew approach for antifilarial therapy||<em>PLoS Negl. Trop. Dis.</em>||Li, Z., Garner, A.L., Gloeckner, C., Janda, K.D.and Carlow, C.K.|
|2011||Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy||PLoS Negl. Trop. Dis.||Li, Z., Garner, A.L., Gloeckner, C., Janda, K.D. and Carlow, C.K.|
|2020||Targeting the oncogene LSF with either the samll molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death of senescence||BMC Cancer||Willoughby, J.L.S., George, K., Roberto, M.P., Chin, H.G., Stoiber, P., Shin, H., Pedamallu, C.S., Schaus, S.E., Fitzgerald, K., Shah, J., Hansen, U.|
|2018||Targeting the sET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development||Oncotarget||Patnaik, D., Estève, P.-O., Pradhan, S|
|2007||Tasting Phenylthiocarbamide (PTC): A New Lab With an Old Flavor.||Am.Biol.Teacher||Merritt, R., Bierwort, L., Slatko, B., Weiner, M., Weiner, E., Ingram, J.and Sciarra, K.|